Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00324207 · ClinicalTrials.gov registry record
Molecular Quantification of Insulin mRNA
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 400
- Enrollment target
NCT00324207 is a clinical trial that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 400 participants.
The verdict
NCT00324207 has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
The objectives of this study are to: 1. quantitate the level of insulin mRNA in the while cell fraction of whole blood in selected groups of subjects, 2. determine the gene expression of markers of white cell activation in the white cell fraction of whole blood in selected subjects, 3. determine the identity of the white cell responsible for expression of insulin mRNA and 4. determine protein expression of mRNA of insulin/proinsulin and selected genes of white cell activation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2006-02 |
| Est. Completion | 2009-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00324207
The ClinicalTrials.gov registry entry for NCT00324207 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00324207 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00324207 about?
NCT00324207 is a clinical study titled "Molecular Quantification of Insulin mRNA". The objectives of this study are to: 1. quantitate the level of insulin mRNA in the while cell fraction of whole blood in selected groups of subjects, 2. determine the gene expression of markers of white cell activation in the white cell fraction of whole blood in selected subjects, 3. determine th...
What is the current status of trial NCT00324207?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2006-02. Estimated completion is 2009-01.
Who is sponsoring clinical trial NCT00324207?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.